| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| vorsetuzumab mafodotin | cd70 antigen | NA | Clinical trial target | TTD | Renal Cell Carcinoma[MeSHID:D002292] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | discontinued in phase 1 | unknown |
| click here to return to the previous page | ||||||||